Amgen partners Israeli biomed

I reported previously (see here) on Israel’s Entera Bio and its treatment for hypoparathyroidism. Entera Bio has just signed a research and licensing agreement with US multinational Amgen to develop a new oral molecule-based treatment that currently is given via IV or injection.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *